Tweetable abstract for social media:
This study aimed to determine the efficacy of nephrin as a biomarker in maternal urine to predict preeclampsia (PE). Patients who had been diagnosed with PE were included and patients without a history of underlying diseases were recruited for the control group. Urine samples were obtained, and nephrin signaling was detected. Nephrin signals were classified into four groups. In the PE group, signals 0, 1, 2, and 3 were found in 18.4%, 44.9%, 24.5%, and 12.2% of participants. In the control group, in which 84.3% were found to have signal 0 (P <0.001). The severity of PE was, however, implied according to the intensity of signals in this study.